Aclaris Therapeutics to Announce Third Quarter 2016 Financial Results on November 3, 2016
October 25 2016 - 8:00AM
Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage
specialty pharmaceutical company, will release its
third quarter financial results before the market opens
on Thursday, November 3, 2016.
Management will conduct a conference call at 8:30 a.m.
ET that day to discuss the Company’s financial results and
provide a general business update. The conference will be
webcast live over the Internet and can be accessed by logging on to
the “Investors” section of the Aclaris Therapeutics
website, www.aclaristx.com, prior to the event. A replay
of the webcast will be archived on the Company’s website for 30
days following the call.
To participate on the live call, please dial (844) 776-7782
(domestic) or (661) 378-9535 (international), and reference
conference ID 97609147 prior to the start of the call.
About Aclaris
Aclaris Therapeutics, Inc. is a clinical-stage specialty
pharmaceutical company focused on identifying, developing, and
commercializing innovative and differentiated drugs to address
significant unmet needs in dermatology. Aclaris
Therapeutics, Inc. is based in Malvern,
Pennsylvania and more information can be found by visiting the
company’s website at www.aclaristx.com.
Contact:
Aclaris Contact
Michael Tung, M.D.
Investor Relations
484-329-2140
mtung@aclaristx.com
Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2023 to Apr 2024